semaglutide compound end date FDA alerts health care providers,

Primary carnitine deficiency is a rare metabolic disorder in which an abnormal gene prevents the body from using certain fats for energy, particularly during long periods without food

The relative abundance of bacterial genera possessing high bile salt hydrolase (BSH) activity, such as Akkermansia and Bacteroides, varies significantly among individuals, potentially modifying the hosts secondary bile acid pool prior to treatment initiation (78, 79)

2BD), the number of pups born per round of copulation per female (Fig

Monday Poster Session Category: Colon P2536 - Emerging Gastrointestinal Risks of GLP-1 Receptor Agonists: A Case of Ischemic Colitis in a Young Woman on Semaglutide Monday, October 27, 2025 10:30 AM - 4:00 PM PDT Location: Exhibit Hall Presenting Author(s) NM Award : ACG Presidential Poster Award Nancy Mayer, DO 1 , Matthew Sutherland, DO 1 , Suchitra Muralidharan, MB, BS 2 , Dhaval Patel, DO 3 1Riverside Medical Center, Bourbonnais, IL

While most adults who have taken GLP-1 drugs say their insurance covered at least a part of the cost of these drugs, about a quarter (27%) of users with health insurance say they paid the full cost of the drugs themselves

Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. Journal of Nutrition and Metabolism, vol